Skip to main content
Top
Literature
1.
go back to reference Genta RM. Gastric cancer: a well-behaved Helicobacter pylori-related disease? Dig Dis Sci. 2011;56:923–925.PubMedCrossRef Genta RM. Gastric cancer: a well-behaved Helicobacter pylori-related disease? Dig Dis Sci. 2011;56:923–925.PubMedCrossRef
2.
go back to reference Uedo N. Do we need multiple biopsies for assessing gastric cancer risk? Dig Dis Sci. 2011;56:926–928.PubMedCrossRef Uedo N. Do we need multiple biopsies for assessing gastric cancer risk? Dig Dis Sci. 2011;56:926–928.PubMedCrossRef
3.
go back to reference Ahn SY, Lee SY, Hong SN, et al. Endoscopic diagnosis of open-type atrophic gastritis is related to the histological diagnosis of intestinal metaplasia and cdx2 expression. Dig Dis Sci. 2011;56:1119–1126.PubMedCrossRef Ahn SY, Lee SY, Hong SN, et al. Endoscopic diagnosis of open-type atrophic gastritis is related to the histological diagnosis of intestinal metaplasia and cdx2 expression. Dig Dis Sci. 2011;56:1119–1126.PubMedCrossRef
4.
go back to reference Tsukanov VV, Butorin NN, Maady AS, et al. Helicobacter pylori infection, intestinal metaplasia, and gastric cancer risk in Eastern Siberia. Helicobacter. 2011;16:107–112. Tsukanov VV, Butorin NN, Maady AS, et al. Helicobacter pylori infection, intestinal metaplasia, and gastric cancer risk in Eastern Siberia. Helicobacter. 2011;16:107–112.
5.
go back to reference Correa P. Chronic gastritis as a cancer precursor. Scand J Gastroenterol. 1984;104:131–136. Correa P. Chronic gastritis as a cancer precursor. Scand J Gastroenterol. 1984;104:131–136.
6.
go back to reference Quach DT, Le HM, Nguyen OT, Nguyen TS, Uemura N. The severity of endoscopic gastric atrophy could help to predict Operative Link on Gastritis Assessment gastritis stage. J Gastroenterol Hepatol. 2011;26:281–285.PubMedCrossRef Quach DT, Le HM, Nguyen OT, Nguyen TS, Uemura N. The severity of endoscopic gastric atrophy could help to predict Operative Link on Gastritis Assessment gastritis stage. J Gastroenterol Hepatol. 2011;26:281–285.PubMedCrossRef
7.
go back to reference Rugge M, Pennelli G, Pilozzi M, et al. Gastritis: the histology report. Dig Liv Dis. 2011;43:S373–S384.CrossRef Rugge M, Pennelli G, Pilozzi M, et al. Gastritis: the histology report. Dig Liv Dis. 2011;43:S373–S384.CrossRef
8.
go back to reference Rugge M, de Boni M, Pennelli G, et al. Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Aliment Pharmacol Ther. 2010;31:1104–1111.PubMed Rugge M, de Boni M, Pennelli G, et al. Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Aliment Pharmacol Ther. 2010;31:1104–1111.PubMed
9.
go back to reference Rugge M, Fassan M, Pizzi M, et al. Operative Link for Gastritis Assessment gastritis staging incorporates intestinal metaplasia subtyping. Hum Pathol. Epub. 2011/04/07. Rugge M, Fassan M, Pizzi M, et al. Operative Link for Gastritis Assessment gastritis staging incorporates intestinal metaplasia subtyping. Hum Pathol. Epub. 2011/04/07.
Metadata
Title
From Open-Type Atrophic Gastritis to Gastritis Staging
Authors
Massimo Rugge
Matteo Fassan
Vladislav V. Tsukanov
Alberto Meggio
Michele de Boni
Publication date
01-06-2011
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 6/2011
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-011-1705-z

Other articles of this Issue 6/2011

Digestive Diseases and Sciences 6/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine